检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Huipeng Jiao Manolis Pasparakis
机构地区:[1]Institute for Genetics,University of Cologne,Cologne,Germany [2]Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases(CECAD),University of Cologne,Cologne,Germany [3]Center for Molecular Medicine(CMMC),University of Cologne,Cologne,Germany.
出 处:《Cell Research》2022年第10期871-872,共2页细胞研究(英文版)
摘 要:Inducing immunogenic cell death in tumors holds promise in stimulating anti-tumor immunity.A recent study published in Nature reported that a small molecule previously shown to induce the formation of Z-DNA activates ZBP1-dependent cell death and renders tumors sensitive to immune checkpoint blockade-based immunotherapy.Cancer immunotherapy by immune checkpoint blockade(ICB)has achieved remarkable success in individual cases;however,these are still restricted to a small number of patients.Therefore,novel approaches to enhance anti-tumor immunity are urgently needed.Induction of immunogenic cell death,such as necroptosis,in tumor cells was shown to synergize with ICB to induce antitumor immune responses in mouse models.1 The RNA-editing enzyme adenosine deaminase acting on RNA 1(ADAR1)has emerged as a novel checkpoint conferring resistance to ICB therapy.
关 键 词:ADAR1 RESISTANCE RENDER
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.66